Specific Anti-SARS-CoV-2 Humoral and Cellular Immune Responses After Booster Dose of BNT162b2 Pfizer-BioNTech mRNA-Based Vaccine: Integrated Study of Adaptive Immune System Components - Busà, Rosalia; Sorrentino, Maria Concetta; Russelli, Giovanna; Amico, Giandomenico; Miceli, Vitale; Miele, Monica; Di Bella, Mariangela; Timoneri, Francesca; Gallo, Alessia; Zito, Giovanni; Di Carlo, Daniele; Conaldi, Pier Giulio; et al. (Frontiers in immunology, 2022)
Keywords: B cells; BNT162 Vaccine; BNT162b2; booster dose; COVID-19 - prevention & control; COVID-19 Vaccines; Humans; Immunity, Cellular; Immunology; mRNA vaccine; mRNA Vaccines; RNA, Messenger - genetics; SARS-CoV-2; T cells; T-Lymphocytes; Vaccines, Synthetic; SARS-CoV-2; BNT162b2; B cells; T cells; booster dose; mRNA vaccine